2025-04-08 18:38:10
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Shalby Ltd Q1FY22 consolidated PAT climbs to Rs. 20.19 crore
Posted On : 2021-08-09 21:24:50( TIMEZONE : IST )
Shalby Limited has reported financial results for the period ended June 30, 2021.
Financial Results (Q1 FY 2021-22) - QoQ Comparison
The company has reported total income of Rs.194.90 crores during the period ended June 30, 2021 as compared to Rs.147.17 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.20.19 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.9.80 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.1.87 for the period ended June 30, 2021 as compared to Rs.0.91 for the period ended March 31, 2021.
| Financials | Q1 FY2021-22 | Q4 FY20-21 | % Change |
| Total Income | ₹ 194.90 crs | ₹ 147.17 crs |  32.43% |
| Net Profit | ₹ 20.19 crs | ₹ 9.80 crs | 106.02% |
| EPS | ₹ 1.87 | ₹ 0.91 | 105.49% |
Financial Results (Q1 FY 2021-22) - YoY Comparison
The company has reported total income of Rs.194.90 crores during the period ended June 30, 2021 as compared to Rs.40.75 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.20.19 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.(8.7) crores for the period ended June 30, 2020.
The company has reported EPS of Rs.1.87 for the period ended June 30, 2021 as compared to Rs.(0.81) for the period ended June 30, 2020.
| Financials | Q1 FY2021-22 | Q1 FY2020-21 | % Change |
| Total Income | ₹ 194.90 crs | ₹ 40.75 crs | 378.28% |
| Net Profit | ₹ 20.19 crs | ₹ (8.7) crs | 332.07% |
| EPS | ₹ 1.87 | ₹ (0.81) | 330.86% |
Commenting on performance, Mr. Shanay Shah, President said: "In Q1 FY2022, Shalby delivered total income of Rs. 1,828 million, an increase of 27.0% on q-o-q basis and 347.9% on y-o-y. EBITDA was Rs. 446 million, an increase of 28.9% on q-o-q, with margins of 24.4%. Shalby operationalized another 24 beds to accommodate additional Covid-19 patients and we have now 1,224 operational beds. Our occupancy levels increased to 59% as compared to 40% in Q4 FY2021. Total 2,813 elective surgeries were performed during the quarter with Critical Care & General Medicine continuing to be major contributor to the revenues. Our topline and profitability was primarily driven by an increase in Covid-19 patients coupled with benefits from structural changes in the cost structure that were being implemented last year.
With the ongoing vaccination program across the country, we are seeing lower Covid-19 cases however, threat of new waves continues to pose a threat. The elective surgeries which were postponed amidst the second wave are expected to recover in the coming quarters. Shalby with its sufficient bed capacity and experienced team of doctors is well positioned to meet the growing demand for affordable and high-quality healthcare services."
Commenting on strategy, Mr. Sushobhan Dasgupta, Vice Chairman and Global President said: "The first quarter of fiscal year saw an unfortunate resurgence of second wave of Covid-19, once again placing responsibility on the healthcare system to support nation in a challenging time. Shalby hospital group remained at the forefront and treated over 5,350 Covid-19 patients in Q1FY22, along with more than 1 Lakh doses of Covid vaccines were administered during the quarter.
Our strategic roadmap is very clear, we will further strengthen our core healthcare service offerings, the rollout of the franchise model was strategically put on hold due to the ongoing pandemic, but we are very optimistic to make substantial progress in the coming quarters, as it will allow Shalby to penetrate deeper into tier-I and tier-II cities.
Shalby has already announced acquisition of implant assets in the USA and we are fully committed to turnaround implant business by end of the next fiscal year and cater to the vast opportunity of implants in India and internationally. With clear strategic direction and Shalby's well established healthcare infrastructure, we are confident of delivering profitable growth across all our business operations and create value for all our stakeholders."
Shares of Shalby Limited was last trading in BSE at Rs. 210.8 as compared to the previous close of Rs. 199.9. The total number of shares traded during the day was 153721 in over 4531 trades.
The stock hit an intraday high of Rs. 213.3 and intraday low of 198. The net turnover during the day was Rs. 31998641.
